CompletedPhase 2NCT00868309
A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab,
Studying Snakebite envenomation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Principal Investigator
- Walter García, MD, MDInstituto Bioclon
- Intervention
- Anavip(biological)
- Enrollment
- 12 target
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2005 – 2007
Study locations (1)
- Tucson snakebite investigational site, Tucson, Arizona, United States
Collaborators
University of Arizona
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00868309 on ClinicalTrials.govOther trials for Snakebite envenomation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07261982Analysis of the Efficacy of Pressure Pad vs Pressure Bandage Immobilisation for Snake Bite First Aid in Healthy Volunteers.Townsville University Hospital
- RECRUITINGNCT06304714Effects of Bothrops Spp. Snake Envenomation on Willebrand Factor Activity in Martinique and French GuianaUniversity Hospital Center of Martinique